Re-evaluation of in vitro activity of primycin against prevalent multiresistant bacteria

Péter Feiszt, Gyula Mestyán, Monika Kerényi, Orsolya Dobay, Judit Szabó, Zsuzsanna Dombrádi, Edit Urbán, Levente Emody

Research output: Contribution to journalArticle

7 Citations (Scopus)


With the increasing emergence of antibiotic resistances old antibiotics became a valuable source to find agents suitable to address this problem. More than 20 years after the last report, our purpose was to re-evaluate the in vitro antibacterial activity of the topical agent primycin against current important bacterial pathogens. Minimal inhibitory concentrations (MIC) and minimal bactericidal concentrations (MBC) of primycin were tested in comparison with agents widely applied topically, and with those of mupirocin and vancomycin, the topical and the non-topical gold-standard anti-MRSA agents. Primycin was ineffective (MIC>64μg/ml) against all the Gram-negative isolates tested. On the other hand, all the tested Gram-positive isolates were susceptible with MIC90 values of 0.06μg/ml for staphylococci and 0.5-1μg/ml for enterococci, streptococci, and P. acnes isolates, including all the multiresistant strains. Against MRSA isolates primycin showed slightly higher activity than mupirocin, and inhibited the mupirocin-resistant strains also. MBC90 values ranged from 0.25 to 2μg/ml for the investigated Gram-positive species. The bactericidal effect proved to be concentration-dependent in time-kill experiments. Spontaneous resistant mutants did not emerge in single-step mutation experiments and the resistance development was very slow by serial passaging. Passaged S. aureus strains showing increased primycin MIC values exhibited elevated vancomycin and daptomycin MIC values also. Though elucidation of the mechanisms behind warrants further investigations, these correlations can be related to development of vancomycin-intermediate phenotype. From the point of view of medical practice it is noteworthy that the increased primycin MIC values remained far below the concentration accessible by local application of the agent. These data make primycin a remarkable object of further investigations as well as a promising candidate for topical application against multiresistant Gram-positive pathogens.

Original languageEnglish
Pages (from-to)1077-1085
Number of pages9
JournalInternational Journal of Medical Microbiology
Issue number8
Publication statusPublished - Nov 1 2014


  • MRSA
  • Primycin
  • Susceptibility
  • Time-kill
  • VISA
  • VRE

ASJC Scopus subject areas

  • Microbiology
  • Microbiology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Re-evaluation of in vitro activity of primycin against prevalent multiresistant bacteria'. Together they form a unique fingerprint.

  • Cite this